International Molecular Diagnostics Congress 2016

Date: 14-15 of September

Location: Barcelona, Spain

Organizer: Genetic Insider

Website: http://genetic-insider.com/diagnostics/

 

More than 20 expert speakers and 130 senior attendees will be at the first commercially focused congress for the diagnostics industry. There, we will discuss the route to unlock Personalized Medicine through companion diagnostics.

 

The 14-15 Sept you’ll learn about trends, new business models, the latest regulatory affairs, ways to increase demand, market access and reimbursement. Join of Caris LifeSciences, Faegre BD, Eugenomic, Paralax Life Sciences, the Personalized Medicine Coalition and many more to go deeper in the industry’s biggest challenges.

 

Download the brochure at www.genetic-insider.com/diagnostics/brochure

 

Why attend?

 

International Molecular Diagnosticss Congress will provide solutions to critical matters from the top industry experts, pharma companies, doctors, Regulatory bodies and other key stakeholders in the diagnostics industry.

 

Genetic insidER will bring together all key stakeholders, so you can identify the following topics to guide the next wave of the diagnostics industry:

 

 • Latest developments and trends in diagnostics technologies in the personalized medicine industry

 • Disruptive and sustainable business models to capture value for Diagnostics

 • Understanding how to increase physician awareness and demand

 • Regulatory frameworks 2.0 – The keys to Market Access

 • The key to American Market Access for European companies

 • Demonstrate the value of diagnostic technologies to secure coverage and payment

 • Clarify the uncertainty on reimbursement and managing stakeholder

 

Agenda

 

Disruptive and sustainable business models to capture value for Diagnostics

 

 • Hear how moving beyond the “one-drug one-diagnostic” paradigm will help your business stay at the top

 • Discover how drug developers and diagnostic developers should collaborate to ensure that both get it right

 • Learn how Multi-dimensional / Multi-Company Investment in diagnostics technologies leads to co-dependent returns in therapeutics and diagnostics

 

Speakers:

 

Jorge León, President and CEO, Leomics Associates Inc

Iain Miller, Founder & CEO, Healthcare Strategies Group

 

Latest developments and trends in diagnostics technologies in the personalized medicine industry

 

 • Understand the potential of new non- invasive diagnostic technologies such as liquid biopsies that lower risk through Non Invasive Prenatal Testing (NIPT) and in tumour diagnosis

 • Hear the latest on Next Generation Sequencing (NGS), a technology at the forefront of personalized medicine’s development, increasing speed and slashing costs drastically

 • Forward growth trends – Consider the growth areas for diagnostic technologies, including opportunities in cardiovascular, inflammatory diseases, oncology and many more.

 • Implementation of next generation sequencing (NGS) for hereditary cancer diagnostics and treatment

 • Towards Targeted Therapeutics: the pharmaceutical industry and Personalized Medicine

 

Speakers:

 

Andreas Voss, VP Clinical Affairs, Caris Life Sciences

Julián Isla, Chairman of the European Delegation, Dravet Syndrome Foundation

Ana Sabater, Associate Director, Eugenomic

Conxi Lázaro, Head of the Molecular Diagnostic Unit Hereditary Cancer, Institut Català d’Oncologia (ICO-IDIBELL)

Jorge León, President and CEO, Leomics Associates Inc

Dvir Dahary, NGS Product Manager, LifeMap Sciences

Javier Suela Rubio, Technical Director, NimGenetics

Paul D. Slowey, Chief Executive Office, Oasis Diagnostics Corporation

Clara Mayo, Director of the Liquid Biopsy Program, Pangaea

Gabor Bethlendy, Chief Commercial Officer, Parabase Genomics

Edward Abrahams, President, Personalized Medicine Coalition

 

Understanding how to increase physician awareness and demand

 

 • Learn how to successfully convey accurate and complete genomic information to the general public through the health care professionals that advise them

 • Take part on the definition of the standard practice of care for doctors for genomic medicine, including the issues should be taken into consideration

 • Consider the new diagnostic technologies from the perspective of various stakeholders to understand the critical success factors of the personalized medicine industry

 • Precision Medicine in the Clinical Workflow: enabling providers to match the right tests and protocols to the individual patient

 

Speakers:

 

Celia Badenas, Senior Specialist, Biomedical Diagnostic, Clinic Hospital

Assaf Halevy, General Manager, 2bPrecise

 

Regulatory Frameworks 2.0 - The keys to Market Access

 • Get an inside track into the differences of European and US legislation on Genetic Testing and Diagnosis

 • Unriddle the complexity of each European country’s coding system to explore the opportunities and hurdles facing the personalised medicine diagnostic technology industry

 • Keys to Market Access in Europe: Learn how to overcome the challenge of market fragmentation in technology evaluation and evidence requirements for diagnostic technology

 

Speaker:

 

Dominique Monferrer, Scientific & Regulatory Affairs Associate Director, Asphalion

 

The key to American Market Access for European Companies

 

 • Listen to best practice tips and advice from key players of US market which you can apply to your own strategy right away

 • Compare suitable market entry and market penetration business models in the Genomics services industry

 • Evaluate new Business-2-Business (B2B) alliances and how these agreements between American and European companies will be vital to reach new markets

 

Speakers:

 

Bruce Quinn, Senior Health Policy Specialist, FaegreBD Consulting

 

Demonstrate the value of diagnostic technologies to secure coverage and payment

 

 • Understand what are the challenges with the current reimbursement model and how it needs to be adapted to unify the changes required by personalized medicine

 • Navigate the complexity of the coding country to country and successfully create new opportunities for your diagnostic technology

 

Speakers:

 

Ernesto Nogueira, Managing Director, ValueConnected

Miguel A. Viribay, PhD. VP Sales and Marketing, Sygnis

 

Clarify the uncertainty on reimbursement and managing stakeholder

 

 • How to work with payers to develop reimbursement processes that work for you and for them and that are best for the end user

 • How to apply proven market access strategies successfully, such as Companion Diagnostics, to secure your products into the market

 • Learn how to create a value proposition for your diagnostics technology and informing stakeholders accordingly

 

Speakers:

 

Dimitar B. Georgiev, Founder and CEO, Paralax Life Sciences

Manuel Pérez Alonso, Director, IMEGEN

 

Contact

Araceli Giner| Congress Organizer
Phone: +34 954 215170
Email: araceli@genetic-insider.com